Peptide Mapping Challenges That An Experienced CDMO Can Solve
Peptide Mapping Challenges That An Experienced CDMO Can Solve Peptide mapping using mass spectrometry is a powerful technique for analyzing proteins, with several challenges that must be navigated. CuriRx effectively and efficiently mitigates all of these challenges by applying multiple techniques based on a wealth of experience in biologics characterization. Here are some of the challenges and CuriRx’s novel approach. Optimized sequence coverage: Large hydrophobic regions can be particularly problematic. We solve this by first
Introducing the new CuriRx, Inc. Newsletter!
WILMINGTON, MA, August 27, 2024— We are excited to introduce the new CuriRx, Inc. Newsletter! Stay informed with the latest industry developments, highlights from client projects, upcoming events, our range of service offerings, and much more. LINK TO Newsletter CuriRx: is a leading Contract Research, Development and Manufacturing Organization (CRDMO) based in Massachusetts, consisting of a minority female entrepreneur and a group of experts with diverse backgrounds. The company specializes in bioprocessing, formulation, and analytical
CuriRx Embraces Collaboration Opportunities at Bioprocessing International Conference 2023
WILMINGTON, MA, September 12, 2023— CuriRx, a pioneering Contract Research, Development, and Manufacturing Organization (CRDMO) based in Massachusetts, is thrilled to announce its participation in the upcoming Bioprocessing International Conference(BPI) at the Boston Convention and Exhibition Center from September 18-21. The event, renowned as the largest gathering in the bioprocessing industry, provides an exceptional platform for professionals to accelerate the journey of promising biologics, cell therapies, and gene therapies toward commercial success. CuriRx welcomes any
CuriRx Launches the Advanced Bioprocessing and Analytical Center to Support Biotherapeutic Drug Developers
WILMINGTON, Mass., Jan. 26, 2022 /PRNewswire/ — CuriRx, Inc., a leading contract research, development and manufacturing organization (CRDMO), announced today the launch of the Advanced Bioprocessing and Analytical Center. Led by CuriRx’s team of industry experts and state-of-the-art bioprocessing laboratories combined with the CuriLytics® Platform’s high-resolution analytical instrumentation, the Advanced Bioprocessing and Analytical Center provides end-to-end support to developers of biotherapeutics. Modern biopharmaceutical drugs, such as recombinant proteins, monoclonal antibodies (mAb), bispecific antibodies, vaccines, antibody